Active, Not Recruiting
Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis
NCT06106672
- Conditions
- AChR Myasthenia Gravis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +13 more
- Locations
-
- Barrow Neurological Institute Phoenix, Arizona, United States
- Infusion for Health Brea, California, United States
- University of California, Irvine Orange, California, United States
- University of California, Davis Sacramento, California, United States